Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
Compare kidney function as measured by calculated creatinine clearance (using the method by
Nankivell)1 at 12 months after transplantation in subjects receiving induction therapy with
cyclosporine microemulsion (CsA) and Rapamune followed by CsA dose reduction (Group I) with
subjects receiving induction therapy with CsA and Rapamune followed by CsA discontinuation
(Group II).